Cargando…

Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease

BACKGROUND: Autosomal dominant polycystic kidney disease (PKD) is the most common genetic renal disease and the fourth leading cause of end-stage renal disease in the United States. Although there is no cure for PKD, several treatments are considered to be beneficial, including blood pressure contro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tran, Wen-Ching, Huynh, David, Chan, Tea, Chesla, Catherine A., Park, Meyeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498983/ https://www.ncbi.nlm.nih.gov/pubmed/28679364 http://dx.doi.org/10.1186/s12882-017-0641-3

Ejemplares similares

Barriers and facilitators to the transplant process among patients living with polycystic kidney disease: a qualitative Approach
por: Smith, Juliana, et al.
Publicado: (2023)

Dialysis or Death: A Qualitative Study of Older Patients’ and Their Families’ Understanding of Kidney Failure Treatment Options in a US Public Hospital Setting
por: Karlin, Jennifer, et al.
Publicado: (2019)

Cardiac function assessed by myocardial deformation in adult polycystic kidney disease patients
por: Lassen, Mats C. H., et al.
Publicado: (2019)

Obesity, Weight Loss, Lifestyle Interventions, and Autosomal Dominant Polycystic Kidney Disease
por: Steele, Cortney, et al.
Publicado: (2022)

Barriers and Facilitators to Weight and Lifestyle Management in Women with Polycystic Ovary Syndrome: General Practitioners’ Perspectives
por: Arasu, Alexis, et al.
Publicado: (2019)

Barriers and Facilitators to the Implementation of Evidence-Based Lifestyle Management in Polycystic Ovary Syndrome: A Narrative Review
por: Blackshaw, Lucinda C. D., et al.
Publicado: (2019)

Recent advances in understanding ion transport mechanisms in polycystic kidney disease
por: Sudarikova, Anastasia V., et al.
Publicado: (2021)

African Americans’ Perceptions of Adherence to Medications and Lifestyle Changes Prescribed to Treat Hypertension
por: Pettey, Christina M., et al.
Publicado: (2016)

Post-Visit Patient Understanding About Newly Prescribed Medications
por: Ho, Timothy, et al.
Publicado: (2021)

Associations of TNFR1 with kidney function outcomes by age, gender, and baseline kidney function status: Data from the Heart and Soul Study
por: Park, Meyeon, et al.
Publicado: (2017)

Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment
por: Parker, Jim, et al.
Publicado: (2022)

Polycystic horseshoe kidney
por: Prasad, A. K., et al.
Publicado: (2013)

Horseshoe polycystic kidney
por: Maple, Hannah, et al.
Publicado: (2013)

Polycystic horseshoe kidney
por: Ram, Rapur, et al.
Publicado: (2013)

Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)
por: Wong, Annette T Y, et al.
Publicado: (2018)

Patient and Medical Oncologists’ Perspectives on Prescribed Lifestyle Intervention—Experiences of Women with Breast Cancer and Providers
por: Balneaves, Lynda G., et al.
Publicado: (2020)

Hepatointestinal complications in polycystic kidney disease
por: Huang, Shih-Ting, et al.
Publicado: (2017)

Prognosis of Vascular Access in Haemodialysis Patients with Autosomal Dominant Polycystic Kidney Disease
por: Lee, Tsung-Lun, et al.
Publicado: (2020)

Unraveling Barriers to a Healthy Lifestyle: Understanding Barriers to Diet and Physical Activity in Patients with Chronic Non-Communicable Diseases
por: Cavallo, Massimiliano, et al.
Publicado: (2023)

Molecular genetic analysis of polycystic kidney disease 1 and polycystic kidney disease 2 mutations in pedigrees with autosomal dominant polycystic kidney disease
por: Bitarafan, Fatemeh, et al.
Publicado: (2019)

Dietary supplements for polycystic ovary syndrome
por: KIANI, AYSHA KARIM, et al.
Publicado: (2022)

Understanding Facilitators and Barriers in the Hospital Discharge Processes of Newly Prescribed Insulin: A Mixed-Methods Study
por: Yu, Cheong M, et al.
Publicado: (2021)

Dietary Aspects and Drug-Related Side Effects in Autosomal Dominant Polycystic Kidney Disease Progression
por: Quiroga, Borja, et al.
Publicado: (2022)

Comparison of Lifestyle in Women With Polycystic Ovary Syndrome and Healthy Women
por: Sedighi, Sedigheh, et al.
Publicado: (2015)

Polycystic ovarian syndrome: Environmental/occupational, lifestyle factors; an overview
por: Kshetrimayum, Chaoba, et al.
Publicado: (2019)

Facilitators and barriers to non-medical prescribing – A systematic review and thematic synthesis
por: Graham-Clarke, Emma, et al.
Publicado: (2018)

Understanding the Determinants of Antimicrobial Prescribing Within Hospitals: The Role of “Prescribing Etiquette”
por: Charani, E., et al.
Publicado: (2013)

Willingness of Patients Prescribed Medications for Lifestyle-Related Diseases to Use Personal Health Records: Questionnaire Study
por: Hirano, Ryoma, et al.
Publicado: (2020)

Beyond polycystic kidney disease
por: Santos, Susana Franco, et al.
Publicado: (2017)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

Using prescribing and toxicology data to determine non-medical prescription drug overdose
por: Huynh, Philip, et al.
Publicado: (2020)

Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients Treated With Tolvaptan
por: Anderegg, Manuel A., et al.
Publicado: (2020)

Developments in the management of autosomal dominant polycystic kidney disease
por: Masoumi, Amirali, et al.
Publicado: (2008)

Effectiveness of Lifestyle Modification in Polycystic Ovary Syndrome Patients with Obesity: A Systematic Review and Meta-Analysis
por: Kim, Chan-Hee, et al.
Publicado: (2022)

Assessment of Dietary Sodium Intake Using the Scored Salt Questionnaire in Autosomal Dominant Polycystic Kidney Disease
por: Wong, Annette T. Y., et al.
Publicado: (2020)

The Effect of Dietary Intervention on Autosomal-Dominant Polycystic Kidney Disease (ADPKD) Patients on Tolvaptan and Their Quality of Life
por: Tarabzuni, Ola
Publicado: (2022)

Dietary, Lifestyle, and Children Health
por: Yu, Xiaoran, et al.
Publicado: (2023)

Correction: Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)
Publicado: (2018)

Lifestyle and environmental contributions to ovulatory dysfunction in women of polycystic ovary syndrome
por: Zhang, Bingqian, et al.
Publicado: (2020)

Lifestyle management in polycystic ovary syndrome – beyond diet and physical activity
por: Cowan, Stephanie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8it05vqbjaikk30jn662361ht2